The longevity-related SIRT1 may improve MASLD by regulating ROS, PGC-1α, FoxO1/3, and AMPK to restore mitochondrial function and reduce steatosis of the liver [35, 66, 71, 93]. Here, PPARGC1A is linked to metabolic dysfunction-associated steatotic liver disease.